TATSIS OURANIA (SVP, CRO) sold 0.6% of their position (260.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $126.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0000875320-26-000120
Officer· SVP, CRO
Since Oct 2019
-1.89K
Net shares
Net seller
$915.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.89K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.63K
Price / share
$485.11
Trade value
$789.27K
% of position
3.3%
2/24/2026
48.65K→47.02K
Common Stock
Direct
Shares
−260.00
Price / share
$486.35
Trade value
$126.45K
% of position
0.6%
2/25/2026
47.02K→46.76K
Total
Net shares
−1.89K
Net value
-$915.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −1.63K | $485.11 | $789.27K | 3.3% | 48.65K | 47.02K |
| Common Stock Direct | 2/25/2026 | S · Sale | −260.00 | $486.35 | $126.45K | 0.6% | 47.02K | 46.76K |
| Total | −1.89K | -$915.72K | ||||||
Derivative Transactions0
No derivative transactions reported